Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Kanduparangi Chooranam: 60 mg/Kg/BW/twice a day A/F 30 days
Control Intervention1: NIL: NIL
Sponsors
Government Siddha Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patient with the symptoms of dry cough, recurrent attacks of dyspnoea,hoarseness of voice,frequent hemming,tightness of chest, profuse sweating & wheezing 2)H/o allergens, sneezing. 3)Patients who are willing to take radiological investigation and provide blood for lab investigation. 4)Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using Mini-Peak flow meter and PEFR below normal range from 250L/min to 150 l/min for men, from 200L/min to 100 L/min for women, for those patients are included. 7)Patients who are willing to do Spirometer study - To estimate Pulmonary Function Test (PFT)
Exclusion criteria
Exclusion criteria: 1)Pregancy 2)Lactating mother 3)Cardiac disease 4)Renal disease 5)Tuberculosis 6)Chronic bronchitis 7)Status asthmaticus 8)Diabetes mellitus 9)Auto immune disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| If during treatment or after treatment reduction of the following symptoms 1.Dry cough 2.Recurrent attacks of dyspnoea 3.Hoarseness of voice 4.Frequent hemming 5.Tightness of chest 6.Profuse sweating 7.Wheezing. Timepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Evaluation of physicochemical, phyto chemical, bio chemical, pharmacological activities of â??Kanduparangi Chooranamâ??. 2.Evaluation of siddha parameters (including Envagai thervu)changes in â??IYA IRAIPPU NOI â?? during trial period. 3.Evaluation of modern parametric changes in â??IYA IRAIPPU NOIâ??. 4.Evaluation of safety profile for acute and sub-acute toxicity of trial drug. Timepoint: 30 days | — |
Countries
India
Contacts
Public ContactDr SJustus Antony MD PhD
Government Siddha Medical College and Hospital
Outcome results
None listed